The panel recommends a performance measure addressing the proportion of children receiving follow-up eye examinations after a screening referral defined as:
Numerator: Number of children from the denominator who completed an eye examination by an optometrist or ophthalmologist within 6 months of a referral from quantitative vision screening.
Denominator: All children who turn 72 months of age by December 31st of the reporting year in the state, a region, or a representative sample, who were referred after quantitative screening (see Table 2) in a medical or community setting between the ages of 36 to <72 months.
In case of multiple services, data should reference the earliest examination by an optometrist or ophthalmologist, which was preceded by a referral from a screening (this performance measure does not include eye examinations not preceded by a referral, or triggered by another reason such as positive family history, neurodevelopmental disorder, or observation of an abnormality).
This measure should be calculated 6 months after the end of the reporting year, in order to account for those children that failed a vision screening between the ages of 67 to <72 months who required time to receive a follow up eye examination.
The following treatment measure addresses the proportion of children with an eye examination found to have visually-significant eye conditions, who receive treatment or additional visits to an ophthalmologist or optometrist.
Numerator: Number of children from the denominator who obtained glasses and/or attended at least one follow-up appointment with an optometrist or ophthalmologist* within 6 months of an eye examination.
Denominator: All children who turn 72 months of age by December 31st of the reporting year in the population, or a representative sample, who were prescribed treatment including glasses and/or instructed by an optometrist or ophthalmologist to return within six months (e.g. for treatment of amblyopia, strabismus, or amblyogenic refractive error21).
* This numerator would be reported by the prescribing ophthalmologist or optometrist.
This measure would provide surveillance of treatment adherence in children with diagnosed vision conditions or amblyogenic refractive error.